Asia PR News

BERLIN, May 31 /PRNewswire-AsiaNet/ –

ProBioGen, Germany, announced today that Virbac has entered into a
licensing agreement with ProBioGen to develop biological product candidates
using ProBioGen’s novel avian cell lines AGE1.

Under the terms of the agreement, Virbac will use the permanent cell lines
based on duck retina AGE1.cr and somite cells AGE1.cs developed by ProBioGen
as the production platform to develop biologicals. The financial details of
the agreement are not disclosed.

"This is a breakthrough in the commercialisation of our avian cell line,"
said Michael Schlenk, CEO of ProBioGen. "The development of new designer cell
lines under the full guidelines of the FDA is a long and challenging process.
We are very proud to have developed such a cell line which not only satisfies
these stringent requirements, but is also safe and cost effective for vaccine
and biological production."

About ProBioGen AG
ProBioGen is a specialist for cell line design, viral vectors, and the
manufacture of glycoproteins for the biopharmaceutical industry. The German
biotechnology company is headquartered in Berlin. Its range of products and
services include the development of highly productive cell lines, the design
of novel cell lines from primary tissue, the manufacture of glycoproteins for
clinical studies and R&D, as well as the production of viral vectors and
antibodies for in vitro diagnostics. ProBioGen possesses the manufacturing
authorization for pharmaceutically usable active substances for testing in
clinical studies and meets the quality standards recommended by the EU (EMEA)
and the FDA. A certified cGMP multipurpose facility is available for contract
production of biopharmaceutical active substances. The Company is specialized
in mammalian cells and combines the know-how of molecular biology scientists
with the experience of experts in cell culture technology and process
engineering. ProBioGen thus accompanies its clients from the early development
of product candidates up to late clinical testing phase.

ProBioGen Contact:

Hing Kin Chan, PhD
Goethestrasse 54
13068 Berlin
Tel: +49-30-924-006-0
Fax: +49-30-924-006-19
e-mail: hingkin.chan@probiogen.de

SOURCE ProBioGen AG; Virbac

CONTACT: Hing Kin Chan, PhD, of ProBioGen AG,
+49-30-924-006-0,
Fax, +49-30-924-006-19,
hingkin.chan@probiogen.de